4 years ago

Characterisation of drug-specific signalling between primary human hepatocytes and immune cells.

Antoine DJ, Kevin Park B, French NS, Elmasry M, Ogese MO, Naisbitt DJ, Betts C, Copple IM, Jenkins RE, Faulkner L, Goldring CE, Malik H
It is now apparent that antigen-specific T-cells are activated in certain patients with drug-induced liver injury (DILI). Since cross-talk between hepatocytes and immune cells is likely to be critical in determining the outcome of drug exposure, the aim of this study was to profile the signals released by drug-treated hepatocytes and to characterise the impact of these molecules on dendritic cells. Human hepatocytes were exposed to three drugs (flucloxacillin, amoxicillin and isoniazid) associated with DILI potentially mediated by the adaptive immune system as drug-specific T-cells have been isolated from DILI patients, and the metabolite nitroso-sulfamethoxazole (SMX-NO). Hepatocyte toxicity, cytokine release and activation of oxidative stress pathways were measured. Supernatants were transferred to monocyte-derived dendritic cells and cell phenotype and function were assessed. High-mobility group box 1 protein (HMGB1) and lactate dehydrogenase release as well as adenosine triphosphate depletion occurred in a drug-, time- and concentration-dependent manner with SMX-NO and flucloxacillin, whereas isoniazid and amoxicillin were non-toxic. Furthermore, drug-induced activation of Nrf2 marker genes was observed when hepatocytes were exposed to test drugs. The disulphide isoform of HMGB1 stimulated dendritic cell cytokine release and enhanced the priming of naive T cells. Incubation of dendritic cells with supernatant from drug-treated hepatocytes resulted in two distinct cytokine profiles. SMX-NO/flucloxacillin stimulated secretion of TNF-á, IL-6, IL-1á and IL-1-â. Isoniazid which did not induce significant hepatocyte toxicity, compared with SMX-NO and flucloxacillin, stimulated the release of a panel of cytokines including the above and IFN-γ, IL-12, IL-17A, IP-10 and IL-10. Collectively, our study identifies drug-specific signalling pathways between hepatocytes and immune cells that could influence whether drug exposure will result in an immune response and tissue injury.

Publisher URL: https://www.ncbi.nlm.nih.gov/pubmed/28444390

DOI: PubMed:28444390

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.